JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99818

Anti-Human IgG4 pFc’ [HP6023] (Biotin)

Be the first to review this product! Submit a review

|

(3 Publications)

Anti-Human IgG4 pFc’ [HP6023] (Biotin) is a secondary antibody that is suitable for Western blot, IHC, ICC/IF, ELISA and more.

- Reacts with the pFc’ portion of the heavy chain of Human IgG4

View Alternative Names

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

1 Images
ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)
  • ELISA

Supplier Data

ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)

ELISA - Anti-Human IgG4 pFc [HP6023] (Biotin) (ab99818)

ELISA plate was coated with purified human IgG1, IgG2, IgG3, and IgG4.

Immunoglobulins were detected with serially diluted ab99818 followed by Streptavidin-HRP.

Key facts

Host species

Mouse

Target species

Human

Target isotype

IgG4

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

Biotin

Excitation/Emission
Applications

Dot, IHC-Fr, ICC/IF, ELISA, WB

applications

Clonality

Monoclonal

Clone number

HP6023

Isotype

IgG3

Light chain type

kappa

Immunogen

Full Length Protein corresponding to Human IGHG4. The exact immunogen used to generate this antibody is proprietary information.

P01861

Specificity

ab99818 reacts with the pFc’ portion of the heavy chain of Human IgG4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>for Dot and slot immunoblotting.</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/2000", "notes":"<p></p>" } } }

Product details

This antibody reacts with the pFc' region of Human IgG4

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.1% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store in the dark

Product protocols

Target data

The protein expressed by the IGHG4 gene is part of the constant region of immunoglobulin heavy chains. Immunoglobulins, or antibodies, are glycoproteins produced by B lymphocytes that can be membrane-bound or secreted. During humoral immunity's recognition phase, membrane-bound immunoglobulins act as receptors. When they bind a specific antigen, they trigger B lymphocytes to undergo clonal expansion and differentiate into plasma cells that secrete immunoglobulins. These secreted immunoglobulins then mediate the effector phase of humoral immunity to eliminate the bound antigens. Each immunoglobulin possesses two antigen binding sites, formed by the variable domains of a heavy chain and an associated light chain, allowing for high affinity binding to specific antigens. These variable domains undergo V-(D)-J rearrangement and may experience somatic hypermutations, facilitating affinity maturation after antigen exposure and selection. This supplementary information is collated from multiple sources and compiled automatically.
See full target information IGHG4

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Antibody therapeutics 6:38-48 PubMed36683766

2023

Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15R complex.

Applications

Unspecified application

Species

Unspecified reactive species

Jihong Chen,Ziyou Shen,Xiaoling Jiang,Zhenzhen Huang,Chongbing Wu,Dongcheng Jiang,Liusong Yin

JCI insight 6: PubMed34582377

2021

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Roland Tschismarov,Raphaël M Zellweger,Min Jie Koh,Yan Shan Leong,Jenny G Low,Eng Eong Ooi,Christian W Mandl,Katrin Ramsauer,Ruklanthi de Alwis

Haemophilia : the official journal of the World Federation of Hemophilia 24:487-491 PubMed29461004

2018

Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Applications

Unspecified application

Species

Unspecified reactive species

B Boylan,C H Miller
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com